Biomed company United Therapeutics is in a strong industry group, and that’s a problem. United Therapeutics’ (UTHR) three-year earnings growth rate is 26%, good enough for an EPS Rating of 89. However, in a leading group, “good enough” isn’t good enough. The top biomeds in Stock Checkup at Investors.com include Alexion Pharmaceuticals (ALXN), Biogen Idec (BIIB) and Celgene (CELG). They carry EPS Ratings of 99, 98 and 95, respectively.